Wuhan Kefuxin Pharmaceutical

Wuhan Kefuxin Pharmaceutical is a China-based pharmaceutical company specializing in the research, development, and manufacturing of chemical drugs and active pharmaceutical ingredients (APIs). Founded in 2004 and headquartered in the Wuhan East Lake High-tech Development Zone, the company focuses on therapeutic areas including cardiovascular disease, anti-infectives, and gastroenterology. Its portfolio includes a range of generic medications such as amlodipine, clopidogrel, and entecavir, produced in its GMP-certified facilities. Kefuxin is recognized as a national high-tech enterprise and emphasizes the integration of R&D with large-scale production to serve both domestic and international markets.